Eupraxia Pharmaceuticals Inc.

EPRX·NASDAQ·$7.53Share Price as of 11/2·$252MMarket Cap as of 11/2

Financials

40-FAnnual report (Canadian)03/13/26 40-FAnnual report (Canadian)03/20/25 40-FAnnual report (Canadian)04/01/24

Disclosures

6-KForeign issuer report10/22/26 6-KForeign issuer report10/15/26 6-KForeign issuer report10/09/26 6-KForeign issuer report09/30/26 6-KForeign issuer report09/08/26

Prospectuses and Registrations

F-10/AProspectus / registration08/19/26 F-10Prospectus / registration08/06/26 F-XProspectus / registration08/06/26 S-8Registration of securities for employees02/05/26 S-8Registration of securities for employees04/05/24

Proxies

No matching filings.

Ownership

SC 13G/ABeneficial ownership (amended)08/13/26 SC 13G/ABeneficial ownership (amended)05/12/26 SC 13D/ABeneficial ownership (amended)03/16/26 SC 13G/ABeneficial ownership (amended)02/17/26 SC 13GBeneficial ownership11/14/25

Other

SUPPLSUPPL09/02/26 EFFECTRequest for effectiveness08/24/26 SUPPLSUPPL02/20/26 SUPPLSUPPL02/18/26 SUPPLSUPPL09/23/25